77 related articles for article (PubMed ID: 2889966)
21. Simultaneous expression of type I procollagen mRNA and albumin in cirrhotic human liver.
Yamada S; Koji T; Hata R; Hirohashi S; Kurata S; Senoo H; Sakakibara K; Hayashi T; Nakane PK
J Clin Lab Anal; 1992; 6(6):351-8. PubMed ID: 1432359
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease.
Schuppan D; Besser M; Schwarting R; Hahn EG
J Clin Invest; 1986 Jul; 78(1):241-8. PubMed ID: 3722378
[TBL] [Abstract][Full Text] [Related]
23. Asymptomatic structural liver disease in hemophilia.
Spero JA; Lewis JH; Van Theil DH; Hasiba U; Rabin BS
N Engl J Med; 1978 Jun; 298(25):1373-8. PubMed ID: 349386
[TBL] [Abstract][Full Text] [Related]
24. A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis.
McDonald JA; Broekelmann TJ; Matheke ML; Crouch E; Koo M; Kuhn C
J Clin Invest; 1986 Nov; 78(5):1237-44. PubMed ID: 3771795
[TBL] [Abstract][Full Text] [Related]
25. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
26. Basement membrane proteins and type III procollagen in murine schistosomiasis.
Parise ER; Summerfield JA; Hahn E; Wiedmann KH; Doenhoff MJ
Trans R Soc Trop Med Hyg; 1985; 79(5):663-70. PubMed ID: 3938089
[TBL] [Abstract][Full Text] [Related]
27. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease.
Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M
J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease.
Okada Y; Shimoe T; Muguruma M; Usumoto R; Tsuji T; Jinno K; Moriwaki S; Shin S; Hakomori S
Am J Pathol; 1988 Feb; 130(2):384-92. PubMed ID: 3341453
[TBL] [Abstract][Full Text] [Related]
29. Connective tissue components of the normal and fibrotic human liver. II. Clinical aspects.
Pott G; Rauterberg J; Voss B; Gerlach U
Klin Wochenschr; 1982 Jan; 60(1):1-7. PubMed ID: 7043067
[TBL] [Abstract][Full Text] [Related]
30. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
31. The significance of variations in the distribution of copper in liver disease.
Goldfischer S; Popper H; Sternlieb I
Am J Pathol; 1980 Jun; 99(3):715-30. PubMed ID: 7386600
[TBL] [Abstract][Full Text] [Related]
32. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
34. Hepatic expression of c-Myb in chronic human liver disease.
Kitada T; Seki S; Nakatani K; Kawada N; Kuroki T; Monna T
Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.
Castilla A; Prieto J; Fausto N
N Engl J Med; 1991 Apr; 324(14):933-40. PubMed ID: 1900574
[TBL] [Abstract][Full Text] [Related]
36. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
37. [Identification of procollagen mRNA in chronic active hepatitis B].
Gillessen A; Högemann B; Hengst K; Domschke W
Z Gastroenterol; 1993 Feb; 31 Suppl 2():28-9. PubMed ID: 7483708
[TBL] [Abstract][Full Text] [Related]
38. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.
Ramm GA; Nair VG; Bridle KR; Shepherd RW; Crawford DH
Am J Pathol; 1998 Aug; 153(2):527-35. PubMed ID: 9708812
[TBL] [Abstract][Full Text] [Related]
39. Localization of type III procollagen aminopeptide antigenicity in hepatocytes from cirrhotic human liver.
Sakakibara K; Igarashi S; Hatahara T
Virchows Arch A Pathol Anat Histopathol; 1985; 408(2-3):219-28. PubMed ID: 3936261
[TBL] [Abstract][Full Text] [Related]
40. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
